HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
Conditions:  Acute Lymphoblastic Leukemia;  Acute Myeloid Leukemia;  Acute Leukemia;  Myelodysplastic Syndromes;  Chronic Myeloid Leukemia;  Chronic Lymphocytic Leukemia;  Myeloproliferative Neoplasm;  Lymphoma;  Chronic Myelomonocytic Leukemia;  Pro-Lymphocytic Leukemia;  M yelofibrosis Interventions:  Drug: Busulfan;  Drug: Fludarabine;  Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT);  Drug: Post-Transplant Cyclophosphamide;  Drug: Mesna;  Drug: Tacrolimus;  Drug: Mycophenolate Mofetil;  Other: Patient Reported Outcomes;  Drug: Melphalan; Â...
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Condition:  Kidney Transplant Rejection Interventions:  Drug: AT-1501;  Drug: Tacrolimus Sponsor:  Eledon Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials